SFX by Ex Libris Inc.

Title:	Examination of the Mode of Action of the Almiramide Family of Natural Products against the Kinetoplastid Parasite Trypanosoma brucei
Source:	Journal of Natural Products [0163-3864] Sanchez, Laura yr:2013

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	do Nascimento, Andrea M. "Bioactive extracts and chemical constituents of two endophytic strains of Fusarium oxysporum." Revista Brasileira de Farmacognosia 22.6 (2012): 1276-1281.
description	2.	Barrett, Michael P. "Potential new drugs for human African trypanosomiasis: some progress at last." Current opinion in infectious diseases 23.6 (2010): 603-608.
description	3.	Dujardin, J. "Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas." Trends in parasitology 26.8 (2010): 395-403.
description	4.	Iwatsuki, M. "In vitro and in vivo antimalarial activity of puberulic acid and its new analogs, viticolins A-C, produced by Penicillium sp. FKI-4410." The Journal of Antibiotics 64.2 (2011): 183-188.
description	5.	Vincent, I. "A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes." PLOS pathogens 6.11 (2010).
description	6.	Chen, Y. "In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi." PLoS neglected tropical diseases 4.9 (2010): 1-11.
description	7.	Cecchi, G. "Towards the Atlas of human African trypanosomiasis." International Journal of Health Geographics [NLM - MEDLINE] 8.1 (2009): 1-12.
description	8.	Linington, R. "Symplocamide A, a Potent Cytotoxin and Chymotrypsin Inhibitor from the Marine Cyanobacterium Symploca sp." Journal of natural products 71.1 (2007): 22-27.
description	9.	Kennedy, Peter G E G. "The continuing problem of human African trypanosomiasis (sleeping sickness)." Annals of neurology 64.2 (2008): 116-26.
description	10.	Kennedy, Peter G E E. "Human African trypanosomiasis of the CNS: current issues and challenges." The journal of clinical investigation 113.4 (2004): 496-504.
description	11.	Dauvilliers, S. "Hypocretin and human African trypanosomiasis." Sleep 31.3 (2008): 348-354.
description	12.	Linington, R. "Venturamides A and B: antimalarial constituents of the panamanian marine Cyanobacterium Oscillatoria sp." Journal of natural products 70.3 (2007): 397-401.
description	13.	Stich, A. "[African sleeping sickness. An ancient threat returns]." Pharmazie in unserer Zeit 38.6 (2009): 546-550.
description	14.	Kennedy, P. "Diagnostic and neuropathogenesis issues in human African trypanosomiasis." International Journal for Parasitology 36.5 (2006): 505-512.
description	15.	Ndung'u, S. "“Piggy-Backing” on Diagnostic Platforms Brings Hope to Neglected Diseases: The Case of Sleeping Sickness." PLoS Neglected Tropical Diseases 4.5 (2010).
description	16.	Kerr, I. "Crystal Structures of TbCatB and Rhodesain, Potential Chemotherapeutic Targets and Major Cysteine Proteases of Trypanosoma brucei." PLoS Neglected Tropical Diseases 4.6 (2010).
description	17.	Senkovich, O. "Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate." Acta crystallographica. Section D, Biological crystallography 65.7 (2009): 704-716.
description	18.	HAGAR, J. "CHAGAS HEART-DISEASE IN THE UNITED-STATES." New England Journal of Medicine, The 325.11 (1991): 763-768.
description	19.	Lim, W. "Chrysophanol Induces Apoptosis of Choriocarcinoma Through Regulation of ROS and the AKT and ERK1/2 Pathways." Journal of cellular physiology 331-339.
description	20.	Simarro, P. "Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis." International Journal of Health Geographics 13.1 (2014): 4-4.